Cargando…

Plasma oxalate and glycolate concentrations in dialysis patients with and without primary hyperoxaluria type 1

Detalles Bibliográficos
Autores principales:	Metry, Elisabeth L, Garrelfs, Sander F, Peters-Sengers, Hessel, Vaz, Frederic M, Bijlsma, Joost A, Neradova, Aegida, Oosterveld, Michiel J S, Groothoff, Jaap W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310499/ https://www.ncbi.nlm.nih.gov/pubmed/36898675 http://dx.doi.org/10.1093/ndt/gfad049

Ejemplares similares

Transplantation outcomes in patients with primary hyperoxaluria: a systematic review
por: Metry, Elisabeth L., et al.
Publicado: (2021)

Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry
por: Metry, Elisabeth L., et al.
Publicado: (2021)

Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium
por: Metry, Elisabeth L., et al.
Publicado: (2023)

Primary hyperoxaluria: the pediatric nephrologist's point of view
por: Ben-Shalom, Efrat, et al.
Publicado: (2022)

Development and Validation of a New Gas Chromatography–Tandem Mass Spectrometry Method for the Measurement of Enrichment of Glyoxylate Metabolism Analytes in Hyperoxaluria Patients Using a Stable Isotope Procedure
por: van Harskamp, Dewi, et al.
Publicado: (2019)

Genetic assessment in primary hyperoxaluria: why it matters
por: Mandrile, Giorgia, et al.
Publicado: (2022)

Improved Outcome of Infantile Oxalosis Over Time in Europe: Data From the OxalEurope Registry
por: Deesker, Lisa J., et al.
Publicado: (2022)

In vivo oxalate degradation by liposome encapsulated oxalate oxidase in rat model of hyperoxaluria
por: Dahiya, Tulika, et al.
Publicado: (2013)

Impact of telehealth interventions added to peritoneal dialysis-care: a systematic review
por: Biebuyck, Geertje K. M., et al.
Publicado: (2022)

The retinal phenotype in primary hyperoxaluria type 2 and 3
por: Birtel, Johannes, et al.
Publicado: (2022)

Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1
por: Dutta, Chaitali, et al.
Publicado: (2016)

A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria
por: Milliner, Dawn, et al.
Publicado: (2017)

Plasma Oxalate as a Predictor of Kidney Function Decline in a Primary Hyperoxaluria Cohort
por: Shah, Ronak Jagdeep, et al.
Publicado: (2020)

In female rats, ethylene glycol treatment elevates protein expression of hepatic and renal oxalate transporter sat-1 (Slc26a1) without inducing hyperoxaluria
por: Breljak, Davorka, et al.
Publicado: (2015)

Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria
por: Lai, Chengjung, et al.
Publicado: (2018)

Hydroxycitric Acid Tripotassium Inhibits Calcium Oxalate Crystal Formation in the Drosophila Melanogaster Model of Hyperoxaluria
por: Han, Shanfu, et al.
Publicado: (2019)

Urinary monocyte chemoattractant protein 1 associated with calcium oxalate crystallization in patients with primary hyperoxaluria
por: Wang, Xiangling, et al.
Publicado: (2020)

An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria
por: Lubkowicz, David, et al.
Publicado: (2022)

Chronic liver disease and hepatic calcium-oxalate deposition in patients with primary hyperoxaluria type I
por: Recker, Pia, et al.
Publicado: (2022)

Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1
por: Hulton, Sally A., et al.
Publicado: (2021)

Dominant negative mutation in oxalate transporter SLC26A6 associated with enteric hyperoxaluria and nephrolithiasis
por: Cornière, Nicolas, et al.
Publicado: (2022)

Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4)
por: Goldfarb, David S., et al.
Publicado: (2023)

Influence of pH and phosphate concentration on the phosphate binding capacity of five contemporary binders. An in vitro study
por: Schumacher, Stefan P, et al.
Publicado: (2018)

Correction to: Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4)
por: Goldfarb, David S., et al.
Publicado: (2023)

Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function—data from three placebo-controlled studies
por: Milliner, Dawn S., et al.
Publicado: (2021)

Simple, fast and inexpensive quantification of glycolate in the urine of patients with primary hyperoxaluria type 1
por: Boehm, Thomas, et al.
Publicado: (2023)

Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures
por: Suryavanshi, Mangesh V., et al.
Publicado: (2016)

Reversal of Gastric Bypass Resolves Hyperoxaluria and Improves Oxalate Nephropathy Secondary to Roux-en-Y Gastric Bypass
por: Agrawal, Varun, et al.
Publicado: (2016)

Transcriptional study of hyperoxaluria and calcium oxalate nephrolithiasis in male rats: Inflammatory changes are mainly associated with crystal deposition
por: Joshi, Sunil, et al.
Publicado: (2017)

Acute oxalate nephropathy caused by ethylene glycol poisoning
por: Seo, Jung Woong, et al.
Publicado: (2012)

Autophagy inhibition attenuates hyperoxaluria-induced renal tubular oxidative injury and calcium oxalate crystal depositions in the rat kidney
por: Duan, Xiaolu, et al.
Publicado: (2018)

Plasma oxalate: comparison of methodologies
por: Stokes, Felicity, et al.
Publicado: (2020)

Diagnostic dilemmas in a girl with acute glomerulonephritis: Questions
por: Falix, Farah A., et al.
Publicado: (2017)

Diagnostic dilemmas in a girl with acute glomerulonephritis: Answers
por: Falix, Farah A., et al.
Publicado: (2017)

Primary Hyperoxaluria
por: Harambat, Jérôme, et al.
Publicado: (2011)

Evaluation of a high‐performance liquid chromatography method for urinary oxalate determination and investigation regarding the pediatric reference interval of spot urinary oxalate to creatinine ratio for screening of primary hyperoxaluria
por: Shen, Ying, et al.
Publicado: (2021)

Oral health in patients with end‐stage renal disease: A scoping review
por: Laheij, Alexa, et al.
Publicado: (2021)

Kidney Injury Molecule-1 Is Up-Regulated in Renal Epithelial Cells in Response to Oxalate In Vitro and in Renal Tissues in Response to Hyperoxaluria In Vivo
por: Khandrika, Lakshmipathi, et al.
Publicado: (2012)

Cerium oxide-based nanozyme suppresses kidney calcium oxalate crystal depositions via reversing hyperoxaluria-induced oxidative stress damage
por: Deng, Jiwang, et al.
Publicado: (2022)

CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I
por: Zabaleta, Nerea, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0n2sksjooen7p62hr603n724en